A recurrent homozygous LMNA missense variant p.Thr528Met causes atypical progeroid syndrome characterized by mandibuloacral dysostosis, severe muscular dystrophy, and skeletal deformities

Atypical progeroid syndromes (APS) are premature aging syndromes caused by pathogenic LMNA missense variants, associated with unaltered expression levels of lamins A and C, without accumulation of wild-type or deleted prelamin A isoforms, as observed in Hutchinson-Gilford progeria syndrome (HGPS) or HGPS-like syndromes. A specific LMNA missense variant, (p.Thr528Met), was previously identified in a compound heterozygous state in patients affected by APS and severe familial partial lipodystrophy, whereas heterozygosity was recently identified in patients affected by Type 2 familial partial lipodystrophy. Here, we report four unrelated boys harboring homozygosity for the p.Thr528Met, variant who presented with strikingly homogeneous APS clinical features, including osteolysis of mandibles, distal clavicles and phalanges, congenital muscular dystrophy with elevated creatine kinase levels, and major skeletal deformities. Immunofluorescence analyses of patient-derived primary fibroblasts showed a high percentage of dysmorphic nuclei with nuclear blebs and typical honeycomb patterns devoid of lamin B1. Interestingly, in some protrusions emerin or LAP2α formed aberrant aggregates, suggesting pathophysiology-associated clues. These four cases further confirm that a specific LMNA variant can lead to the development of strikingly homogeneous clinical phenotypes, in these particular cases a premature aging phenotype with major musculoskeletal involvement linked to the homozygous p.Thr528Met variant.

[1]  Á. Hermida-Ameijeiras,et al.  Variable Expressivity and Allelic Heterogeneity in Type 2 Familial Partial Lipodystrophy: The p.(Thr528Met) LMNA Variant , 2021, Journal of clinical medicine.

[2]  Daniel D. Miller,et al.  Diffuse, mottled hyperpigmentation and mutations in LMNA gene in a 5‐year‐old boy, his mother, and his grandmother: Atypical progeroid syndrome , 2019, Pediatric dermatology.

[3]  S. Pruhova,et al.  Short stature in a boy with atypical progeria syndrome due to LMNA c.433G>A [p.(Glu145Lys)]: apparent growth hormone deficiency but poor response to growth hormone therapy , 2019, Journal of pediatric endocrinology & metabolism : JPEM.

[4]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[5]  S. Young,et al.  LMNA missense mutations causing familial partial lipodystrophy do not lead to an accumulation of prelamin A , 2016, Nucleus.

[6]  Shuyang Zhang,et al.  A Case of Novel Lamin A/C Mutation Manifesting as Atypical Progeroid Syndrome and Cardiomyopathy. , 2016, The Canadian journal of cardiology.

[7]  V. Quesada,et al.  Novel LMNA mutations cause an aggressive atypical neonatal progeria without progerin accumulation , 2016, Journal of Medical Genetics.

[8]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[9]  P. Taimen,et al.  Gene-rich chromosomal regions are preferentially localized in the lamin B deficient nuclear blebs of atypical progeria cells , 2015, Nucleus.

[10]  Ming Yan,et al.  Mandibuloacral dysplasia type A-associated progeria caused by homozygous LMNA mutation in a family from Southern China , 2014, BMC Pediatrics.

[11]  Yun Bai,et al.  p.Pro4Arg mutation in LMNA gene: a new atypical progeria phenotype without metabolism abnormalities. , 2014, Gene.

[12]  D. Judge,et al.  LMNA‐associated cardiocutaneous progeria: An inherited autosomal dominant premature aging syndrome with late onset , 2013, American journal of medical genetics. Part A.

[13]  Katherine H. Schreiber,et al.  When Lamins Go Bad: Nuclear Structure and Disease , 2013, Cell.

[14]  N. Lévy,et al.  An inherited LMNA gene mutation in atypical Progeria syndrome , 2012, American journal of medical genetics. Part A.

[15]  K. McBride,et al.  Coronary artery disease in a Werner syndrome‐like form of progeria characterized by low levels of progerin, a splice variant of lamin A , 2011, American journal of medical genetics. Part A.

[16]  K. Mamchaoui,et al.  Type B mandibuloacral dysplasia with congenital myopathy due to homozygous ZMPSTE24 missense mutation , 2011, European Journal of Human Genetics.

[17]  Y. Crow,et al.  Atypical progeroid syndrome due to heterozygous missense LMNA mutations. , 2009, The Journal of clinical endocrinology and metabolism.

[18]  I. Hausmanowa-Petrusewicz,et al.  Progeroid syndrome with scleroderma‐like skin changes associated with homozygous R435C LMNA mutation , 2009, American journal of medical genetics. Part A.

[19]  Xuefan Gu,et al.  Homozygous LMNA mutation R527C in atypical Hutchinson–Gilford progeria syndrome: evidence for autosomal recessive inheritance , 2009, Acta paediatrica.

[20]  E. Meshorer,et al.  Nuclear lamins: key regulators of nuclear structure and activities , 2009, Journal of cellular and molecular medicine.

[21]  I. Hausmanowa-Petrusewicz,et al.  Progeria caused by a rare LMNA mutation p.S143F associated with mild myopathy and atrial fibrillation. , 2008, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[22]  W. Kress,et al.  Association of homozygous LMNA mutation R471C with new phenotype: Mandibuloacral dysplasia, progeria, and rigid spine muscular dystrophy , 2008, American journal of medical genetics. Part A.

[23]  A. Vielle,et al.  Compound heterozygosity for mutations in LMNA in a patient with a myopathic and lipodystrophic mandibuloacral dysplasia type A phenotype. , 2007, The Journal of clinical endocrinology and metabolism.

[24]  H. Worman,et al.  "Laminopathies": a wide spectrum of human diseases. , 2007, Experimental cell research.

[25]  R. Hennekam Hutchinson–Gilford progeria syndrome: Review of the phenotype , 2006, American journal of medical genetics. Part A.

[26]  H. Smeets,et al.  Compound heterozygosity for mutations in LMNA causes a progeria syndrome without prelamin A accumulation. , 2006, Human molecular genetics.

[27]  A. Garg,et al.  Laminopathies: multisystem dystrophy syndromes. , 2006, Molecular genetics and metabolism.

[28]  L. Mestroni,et al.  Thymopoietin (lamina‐associated polypeptide 2) gene mutation associated with dilated cardiomyopathy , 2005, Human mutation.

[29]  G. Novelli,et al.  Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment , 2005, Cellular and Molecular Life Sciences.

[30]  E. Bertini,et al.  Dominant LMNA mutations can cause combined muscular dystrophy and peripheral neuropathy , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[31]  A. K. Agarwal,et al.  Compound heterozygous ZMPSTE24 mutations reduce prelamin A processing and result in a severe progeroid phenotype , 2005, Journal of Medical Genetics.

[32]  C. López-Otín,et al.  Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors. , 2005, Human molecular genetics.

[33]  C. Bönnemann,et al.  p.S143F mutation in lamin A/C: A new phenotype combining myopathy and progeria , 2005, Annals of neurology.

[34]  J. Broers,et al.  Laminopathies , 2004, The Journal of pathology.

[35]  P. Vermersch,et al.  Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities. , 2004, The Journal of clinical endocrinology and metabolism.

[36]  R. Hennekam,et al.  Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy. , 2004, Human molecular genetics.

[37]  Jimmy D Bell,et al.  Familial partial lipodystrophy associated with compound heterozygosity for novel mutations in the LMNA gene , 2004, Diabetologia.

[38]  G. Boriani,et al.  Mutation analysis of the lamin A/C gene (LMNA) among patients with different cardiomuscular phenotypes , 2003, Journal of medical genetics.

[39]  A. K. Agarwal,et al.  Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. , 2003, Human molecular genetics.

[40]  Pierre Cau,et al.  Lamin A Truncation in Hutchinson-Gilford Progeria , 2003, Science.

[41]  A. K. Agarwal,et al.  Genetic and phenotypic heterogeneity in patients with mandibuloacral dysplasia-associated lipodystrophy. , 2003, The Journal of clinical endocrinology and metabolism.

[42]  Laura Scott,et al.  Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome , 2003, Nature.

[43]  R. Hegele,et al.  LMNA is mutated in Hutchinson-Gilford progeria (MIM 176670) but not in Wiedemann-Rautenstrauch progeroid syndrome (MIM 264090) , 2003, Journal of Human Genetics.

[44]  P. Reiss,et al.  Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy. , 2002, Neurology.

[45]  G. Scarano,et al.  Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. , 2002, American journal of human genetics.

[46]  S. Zinn-Justin,et al.  The Ig-like structure of the C-terminal domain of lamin A/C, mutated in muscular dystrophies, cardiomyopathy, and partial lipodystrophy. , 2002, Structure.

[47]  S. Ishiura,et al.  Interaction between emerin and nuclear lamins. , 2001, Journal of biochemistry.

[48]  R. Foisner,et al.  Lamina-associated polypeptide 2alpha binds intranuclear A-type lamins. , 2000, Journal of cell science.

[49]  F. Muntoni,et al.  Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy , 1999, Nature Genetics.

[50]  V. McKusick,et al.  New syndrome manifested by mandibular hypoplasia, acroosteolysis, stiff joints and cutaneous atrophy (mandibuloacral dysplasia) in two unrelated boys. , 1971, Birth defects original article series.

[51]  A. Kupfer,et al.  The processing pathway of prelamin A. , 1994, Journal of cell science.